Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: A feasibility study

Diabetes Technology and Therapeutics

Volumn 11, Issue 5, 2009, Pages 293-299

  Logtenberg, Susan J J ^a   Kleefstra, Nanne ^a,b   Groenier, Klaas H ^c,d   Gans, Rijk O B ^c,d   Bilo, Henk J G ^a,c,d  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSOR;

ADULT; BIOSENSING TECHNIQUES; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEAR; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT EDUCATION AS TOPIC; RANDOM ALLOCATION;

EID: 66749113993     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0088     Document Type: Article

References (27)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:854-865.
3. Renard E, Schaepelynck-Bélicar P; EVADIAC Group: Im-plantable insulin pumps. A position statement about their clinical use. Diabetes Metab 2007;33:158-166.
4. DeVries JH, Eskes SA, Snoek FJ, Pouwer F, Van Ballegooie E, Spijker AJ, Kostense PJ, Seubert M, Heine RJ: Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycemic control and hospital stay. Diabet Med 2002;19:496-501.
5. Selam JL: External and implantable insulin pumps: current place in the treatment of diabetes. Exp Clin Endocrinol Diabetes 2001;109(Suppl):S333-S340.
6. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 2008; 31(Suppl):S12-S54.
7. Buckingham B, Caswell K, Wilson DM: Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes Obes 2007;14:288-295.
8. Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH: Nocturnal hypoglycemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med 2007;24:527-532.
9. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113.
10. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27: 734-738.
11. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
12. Renard E, Panteleon AE, Kolopp M, Rebrin K, Steil G: Efficacy of closed-loop control of blood glucose and characterization of delays based on an implantable IV sensor and intraperitoneal insulin pump [abstract]. Diabetologia 2004; 47(Suppl 1):A92.
13. Renard E, Costalat G, Chevassus H, Bringer J: Artificial β-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 2006;32:497-502.
14. Peyrot M, Rubin RR: Patient-reported outcomes (PRO) for an integrated real-time continuous glucose monitoring/ insulin pump (RT-CGM/CSII) system [abstract]. Diabetes 2007;56:A122-A123.
15. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J: Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987;10:617-621.
16. Snoek FJ, Pouwer F, Mollema ED, Heine RJ: [The Dutch version of the Hypoglycemia Fear Survey: internal consistency and validity]. Gedrag Gezond 1996;24:287-292.
17. Logtenberg SJJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJG: Marked improvement of glycemic control, and more time in euglycemia without increase of hypoglycemia with CIPII compared to CSII in type 1 diabetes [abstract]. Diabetologia 2008;51(Suppl 1):A182.
18. Hills M, Armitage P: The two period cross-over clinical trial. Br J Clin Pharmacol 1979;8:7-20.
19. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310.
20. Golicki DT, Golicka D, Groele L, Pankowska E: Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2008;51:233-240.
21. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, TubianaRufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
22. Kovatchev B, Anderson S, Heinemann L, Clarke W: Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008;31:1160-1164.
23. Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA; DirecNet Study Group: The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007;30:59-64.
24. Wolpert HA: The nuts and bolts of achieving end points with real-time continuous glucose monitoring. Diabetes Care 2008;31(Suppl):S146-S149.
25. Snoek FJ, van der Ven NC, Lubach CH, Chatrou M, Ader HJ, Heine RJ, Jacobson AM: Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study. Patient Educ Couns 2001;45:143-148.
26. Schaepelynck Bélicar P, Vague P, Lassmann-Vague V: Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps. Diabetes Metab 2003;29:344-348.
27. Nathan DM, Dunn FL, Bruch J, McKitrick C, Larkin M, Haggan C, Lavin-Tompkins J, Norman D, Rogers D, Simon D: Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypo-glycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Am J Med 1996;100:412-417.